Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | G6PD | P11413 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4851263 | 0.84 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1000014 | 0.84 | MMP2 (0.54) | MMP2CA12CA1CA2CA7 | |
| SCHEMBL19972006 | 0.81 | ALDH1A1 (0.45) | MMP2HDAC3HDAC1HDAC2MAPK1 | |
| SCHEMBL30742728 | 0.81 | ALDH1A1 (0.45) | MMP2HDAC3HDAC1HDAC2MAPK1 | |
| SCHEMBL18043789 | 0.79 | MMP2 (0.50) | MMP2CA12CA1CA2CA7 | |
| SCHEMBL1211014 | 0.76 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29409634 | 0.76 | CA12 (0.70) | MMP2CA12CA1CA2CA7 | |
| SCHEMBL29367294 | 0.76 | MMP2 (0.63) | MMP2CA12CA1CA2CA7 | |
| SCHEMBL15869337 | 0.76 | MMP2 (0.63) | MMP2CA12CA1CA2CA7 | |
| SCHEMBL689217 | 0.76 | CA12 (0.70) | MMP2CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104070307-B | Solder flux composition and solder composition | 株式会社田村制作所 | 2018-02-23 | — | — | CN | claimed |
| US-10220100-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM KEITH R (US) | 2019-03-05 | — | — | US | disclosed |
| US-20180369395-A9 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | LATHAM KEITH R (US) | 2018-12-27 | — | — | US | disclosed |
| US-20180117164-A1 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | LATHAM KEITH R (US) | 2018-05-03 | — | — | US | disclosed |
| CN-104070307-B | Solder flux composition and solder composition | 株式会社田村制作所 | 2018-02-23 | — | — | CN | disclosed |
| CN-104395291-B | N-ethyl-4-hydroxy-1-methyl-5- (methyl (2,3,4,5, 6-pentahydroxyhexyl) amino) -2-oxo-N-phenyl-1, 2-dihydroquinoline-3-carboxamide | 泰华制药工业有限公司 | 2017-07-28 | — | — | CN | disclosed |
| US-9144613-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM KEITH R (US) | 2015-09-29 | — | — | US | disclosed |
| US-9125946-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | LATHAM KEITH R (US) | 2015-09-08 | — | — | US | disclosed |
| CN-104395291-A | N-ethyl-4-hydroxy-1-methyl-5- (methyl (2,3,4,5, 6-pentahydroxyhexyl) amino) -2-oxo-N-phenyl-1, 2-dihydroquinoline-3-carboxamide | TEVA PHARMA | 2015-03-04 | — | — | CN | disclosed |
| CN-104070307-A | FLUX COMPOSITION AND SOLDER COMPOSITION | TAMURA SEISAKUSHO KK | 2014-10-01 | — | — | CN | disclosed |
| US-20130018026-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| WO-2013010102-A2 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | LATHAM KEITH R (US) | 2013-01-17 | — | — | WO | disclosed |
| EP-2252605-A2 | LABELLED ANALOGUES OF HALOBENZAMIDES AS MULTIMODAL RADIOPHARMACEUTICALS AND THEIR PRECURSORS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009095872-A2 | LABELLED ANALOGUES OF HALOBENZAMIDES AS MULTIMODAL RADIOPHARMACEUTICALS AND THEIR PRECURSORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-08-06 | — | — | WO | disclosed |
| EP-1777215-A1 | METHOD FOR PRODUCING 2-AMINO-5-IODOBENZOIC ACID | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-04-25 | — | — | EP | disclosed |
| EP-0147211-B1 | 4H-3,1-BENZOXAZIN-4-ONES AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | SYNTEX (U.S.A.) INC. (US) | 1990-09-12 | — | — | EP | disclosed |
| US-4657893-A | ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-04-14 | — | — | US | disclosed |
| EP-0147211-A2 | 4H-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation | SYNTEX (U.S.A.) INC. (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4337270-A | ANTIALLERGENS; ANTIANAPHYLACTIC AGENTS | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1982-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018026-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | COMT, GPX4, GPX1 | MMP2 78/4885CA12 1825/4885CA1 2099/4885 |
| US-20180369395-A9 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | COMT, GPX4, GPX1 | MMP2 78/4885CA12 1825/4885CA1 2099/4885 |
| US-10220100-B2 | Halogenated phenols for diagnostics, antioxidant protection and drug delivery | COMT, GPX4, GPX1 | MMP2 78/4885CA12 1825/4885CA1 2099/4885 |
| US-20180117164-A1 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | COMT, GPX4, GPX1 | MMP2 78/4885CA12 1825/4885CA1 2099/4885 |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | TYR, PRDX5, PPARG | MMP2 834/4885CA12 3118/4885CA1 4349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.